Supplementary data for manuscript "DNA methylation haplotype block markers efficiently discriminate follicular thyroid carcinoma from follicular adenoma"

<b>Supplementary Data 1 </b>Details of clinical and molecular features in thyroid neoplasms.<b></b> <b>Supplementary Data 2 </b>DMCs markers that specific for FTC or FA samples.<b></b> <b>Supplementary Data 3</b> Characteristics of candidate methylation markers in identification FTC from FA samples <b>Supplementary Data 4 </b>Differentially Methylated in FTC and GO Analysis Results<b></b> <b>Supplementary Data 5 </b>Classification of 26 patients according to their DNA methylation score and pathology <br>

<b>补充数据1</b> 甲状腺肿瘤（thyroid neoplasms）临床与分子特征详情。<b></b> <b>补充数据2</b> 滤泡状甲状腺癌（Follicular Thyroid Carcinoma, FTC）与滤泡状腺瘤（Follicular Adenoma, FA）样本特异性差异甲基化胞嘧啶（Differentially Methylated Cytosines, DMCs）标志物。<b></b> <b>补充数据3</b> 用于区分滤泡状腺瘤（FA）与滤泡状甲状腺癌（FTC）样本的候选甲基化标志物特征 <b>补充数据4</b> 滤泡状甲状腺癌（FTC）差异甲基化分析及基因本体（Gene Ontology, GO）富集分析结果<b></b> <b>补充数据5</b> 基于DNA甲基化评分与病理结果的26例患者分类信息<br>